Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00698737 · ClinicalTrials.gov registry record
Treatment Study: Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine (ARC)
A clinical trial, sponsored by Wayne State University.
- Completed
- Registry status
- 22
- Enrollment target
NCT00698737 is a clinical trial that has completed, run by Wayne State University. The registered enrollment target is 22 participants.
The verdict
NCT00698737 has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- 22 participants
- Enrollment target
Study Summary
This research study takes place at Wayne State University and will take about 11 weeks to complete. This is a treatment research study for individuals who currently have cocaine abuse or dependence, and who may also have heroin dependence. The purpose of this study is to test whether oral sustained release d-amphetamine (SR-AMP) is safe and more effective than placebo for preventing relapse to cocaine use for individuals who abuse or are dependent upon cocaine. We are also interested whether, for patients who are dependent on cocaine and heroin, whether SR-AMP is safe and effective for preventing cocaine relapse in combination with buprenorphine.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2008-04 |
| Est. Completion | 2012-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00698737
The ClinicalTrials.gov registry entry for NCT00698737 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00698737 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00698737 about?
NCT00698737 is a clinical study titled "Treatment Study: Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine (ARC)". This research study takes place at Wayne State University and will take about 11 weeks to complete. This is a treatment research study for individuals who currently have cocaine abuse or dependence, and who may also have heroin dependence. The purpose of this study is to test whether oral sustained ...
What is the current status of trial NCT00698737?
This trial is currently completed. The enrollment target is 22 participants. The study started on 2008-04. Estimated completion is 2012-11.
Who is sponsoring clinical trial NCT00698737?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.